Toshiba’s Wall Motion Tracking Provides Worry-Free Experience with Accurate Analysis of Cardiac Function
Industry-Leading Depth and Detail Showcased at ASE
PORTLAND, Ore., June 20, 2014 – To help identify early stages of cardiovascular disease, Toshiba America Medical Systems, Inc. will showcase its AplioTM 500 CV, 300 CV and ArtidaTM with Wall Motion Tracking at this year’s American Society of Echocardiography (ASE) annual meeting in Portland, Ore., June 20–24, 2014 (Booth #307).
The Aplio 500 CV and 300 CV are premier systems for all 2D cardiovascular exams. The systems feature Toshiba’s 2D Wall Motion Tracking technology, providing exceptional visualization and quantitative analysis of myocardial wall motion with accuracy and reproducibility. Through the use of on-board cardiac quantification measurements in all directions (radial, circumferential, 2D rotation and longitudinal), Toshiba’s Aplio CV systems are designed to provide comprehensive information at the patient’s bedside.
The Aplio Artida is Toshiba’s flagship cardiovascular ultrasound system, offering 3D Wall Motion Tracking software, which provides accurate and reproducible quantitative analysis of cardiac function. The Artida’s enhanced single-beat 3D acquisition allows physicians to obtain high-quality 3D images on a wider range of patients, including those with arrhythmias and shortness of breath.
“Toshiba’s ultrasound systems with Wall Motion Tracking are designed to put customers first, providing clear imaging for improved diagnoses on every exam,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “Physicians are given exceptional image quality, which helps to identify early stages of cardiac disease for better patient care.”
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.
Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical product and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation” and is contributing to the achievement of a world in which people everywhere live in safe, secure and comfortable society.
Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sale surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.
SOURCE: Toshiba Medical Systems Corporation